510(k) Report

510(k) · Cleared

Cleared

FREND™ Free T4 Test System

K152422510(k) TraditionalCleared Feb 17, 2016175-day reviewClass II21 CFR 862.1695

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nanoentek USA, Inc. · CEC Radioimmunoassay, Free Thyroxine

Cleared on Feb 17, 2016 as substantially equivalent to K123379 (Abbott Laboratories, 2012) after a 175-day review. Its family tree reaches back 2 generations to 1998.

Decided
Feb 17, 2016
Review
175 days
Class
Class II
Product code
CEC
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K983417 (1998). No later device cites it as a predicate yet.

  1. Root · 2 generations backK983417 Abbott Architect Free T4Abbott Laboratories · 1998 · Recalled
  2. 1 generation backK123379 Abbott Architect Free T4Abbott Laboratories · 2012
  3. This deviceK152422 FREND™ Free T4 Test SystemNanoentek USA, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K983417Abbott Architect Free T4Abbott Laboratories19982
−1K123379Abbott Architect Free T4Abbott Laboratories2012—
0 (this device)K152422FREND™ Free T4 Test SystemNanoentek USA, Inc.2016—
FIG. 1 — Lineage of K152422, 1998–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CEC device

  1. #1 K240273 Access Free T4score 7.0 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K123379Abbott Architect Free T4
Summary page 7
…Abbott ARCHITECT Free T4 Item FREND™ Free T4 Test System (K123379) The FREND™ Free T4 Test System The ARCHITECT Free T4 (FT4) is a is a rapid in…
Abbott Laboratories2012—

Also cleared against K123379: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 14.0 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 1 other device also cites its predicate K123379.

How does its category compare?

All CEC devices

CEC Radioimmunoassay, Free Thyroxine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · CEC

1in 2024

2007: 12008: 22009: 12012: 12013: 22014: 32015: 12016: 12017: 12018: 22023: 12024: 1
2007high 3 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CEC

238in 2014

2014: 238 days median
2007high 238 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CEC

1in 2018

2010: 32013: 12018: 1
2007high 3 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEC

213in 2025

2009: 22010: 72011: 152012: 62013: 62014: 402015: 1662016: 1482017: 1962018: 1992019: 1672020: 1062021: 962022: 812023: 992024: 2762025: 213
2007high 276 (2024) · low 0 (2007)2025

MAUDE reports naming product code CEC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20091—02
20100—37
20110—015
20121—06
20132—16
20143238040
20151—0166
20161—0148
20171—0196
20182—1199
20190—0167
20200—0106
20210—096
20220—081
20231—099
20241—0276
20250—0213
20260—0—

What is it indicated for?

The FREND™ Free T4 Test System is a rapid indirect competitive immunoassay for the quantitative determination of

free thyroxine (FT4) in human serum and lithium heparinized plasma specimens using the FREND™ Free T4 system.

Measurements of free thyroxine (FT4) are used in the diagnosis of thyroid disorders. The FREND™ Free T4 Test System

is intended for use in clinical laboratories. For in vitro diagnostic use only. The test is not intended for point-of-care

facilities.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K152422: FREND™ Free T4 Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K152422

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026